Daiichi Sankyo Company, Limited (DSNKY)
OTCMKTS · Delayed Price · Currency is USD
24.15
-0.40 (-1.63%)
Jun 6, 2025, 1:07 PM EDT

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2013 - 2020
Healthcare (OTC) Products
86.59B
Log In
Log In
Log In
Log In
Upgrade
Healthcare (OTC) Products Growth
14.09%
Log In
Log In
Log In
Log In
Upgrade
Other
2.69B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
13.06%
Log In
Log In
Log In
Log In
Upgrade
Prescription Drugs
1,796.97B
Log In
Log In
Log In
Log In
Upgrade
Prescription Drugs Growth
17.96%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is April - March.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2013 - 2020
Japan Revenue
583.80B
Log In
Log In
Log In
Log In
Upgrade
Japan Revenue Growth
-2.70%
Log In
Log In
Log In
Log In
Upgrade
Europe Revenue
418.21B
Log In
Log In
Log In
Log In
Upgrade
Europe Revenue Growth
34.54%
Log In
Log In
Log In
Log In
Upgrade
North America Revenue
-
Log In
Log In
Log In
Log In
Upgrade
North America Revenue Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Regions Revenue (Pre-FY2025 Reporting) M
-
Log In
Log In
Log In
Log In
Upgrade
Other Regions Revenue (Pre-FY2025 Reporting) M Growth
-
Log In
Log In
Log In
Log In
Upgrade
United States Revenue
642.22B
Log In
Log In
Log In
Log In
Upgrade
United States Revenue Growth
30.37%
Log In
Log In
Log In
Log In
Upgrade
Other Regions Revenue (Post-FY2024 Reporting) M
242.03K
Log In
Log In
Log In
Log In
Upgrade
Other Regions Revenue (Post-FY2024 Reporting) M Growth
22.08%
Log In
Log In
Log In
Log In
Upgrade